{
    "clinical_study": {
        "@rank": "25115", 
        "arm_group": [
            {
                "arm_group_label": "cedar honey", 
                "arm_group_type": "Active Comparator", 
                "description": "The two study groups were provided with standard treatment(dexamethasone and Fluconazole).The Case group(A) received  cedar honey, 20 ml 3 times daily by swish and swallow technique, in addition to the standard treatment ."
            }, 
            {
                "arm_group_label": "control group", 
                "arm_group_type": "No Intervention", 
                "description": "the control group (B) only received standard treatment(Dexametazone and Fluconazole)."
            }
        ], 
        "brief_summary": {
            "textblock": "The study aimed to evaluate the effect of cedar honey in  treatment of erosive and atrophic\n      oral lichen planus ( a common oral problem)."
        }, 
        "brief_title": "Cedar Honey in Oral Lichen Planus", 
        "completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "condition": "Erosive and Atrophic Oral Lichen Planus", 
        "condition_browse": {
            "mesh_term": [
                "Lichen Planus", 
                "Lichen Planus, Oral", 
                "Atrophy"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. clinically and histopathologically confirmed oral lichen planus without dysplasia in\n             histopathologic evaluation\n\n          2. Severity of pain\u22652 (VAS score)\n\n          3. Severity of lesions\u22652 (tong prasom criteria)\n\n          4. absence of any treatment in the last month\n\n          5. absence of kidney or liver diseases( due to systemic administration of fluconazole to\n             both groups)\n\n        Exclusion Criteria:\n\n          1. evidence of lichenoid reaction in clinical or histopathologic assessment\n\n          2. loss of follow up\n\n          3. pregnant patients\n\n          4. diabetic patients\n\n          5. any other mucosal disease\n\n          6. any severe systemic disease\n\n          7. patients who refuse doctor's advice\n\n          8. any unexpected adverse effect of honey"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "36", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01974414", 
            "org_study_id": "900166"
        }, 
        "intervention": {
            "arm_group_label": "cedar honey", 
            "intervention_name": "orally administered cedar honey", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "oral lichen planus", 
            "cedar honey", 
            "atrophic", 
            "erosive", 
            "pain", 
            "treatment", 
            "clinical trial"
        ], 
        "lastchanged_date": "October 26, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Mashhad", 
                    "country": "Iran, Islamic Republic of", 
                    "state": "Khorasan Razavi"
                }, 
                "name": "Oral Medicine Department of Mashhad dental School,Oral and Maxillofacial diseases research center"
            }
        }, 
        "location_countries": {
            "country": "Iran, Islamic Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Cedar Honey in Treatment of Oral Lichen Planus: a Randomized Clinical Trial", 
        "other_outcome": {
            "description": "Pain or burning sensation was assessed by using a visual analog scale (VAS). Patients marked the point from 0(no pain) to 10(extreme pain) representing their present pain perception", 
            "measure": "pain of lesions", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "overall_official": {
            "affiliation": "Mashhad University of Medical Sciences", 
            "last_name": "Majid Sanatkhani, Assistant Professor", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Iran: Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "September 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "severity of lesions due to thong prasom criteria", 
            "measure": "severity of lesions", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01974414"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Mashhad University of Medical Sciences", 
            "investigator_full_name": "Pegah Mosannen Mozafari", 
            "investigator_title": "Assistant professor of Oral medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "A sterile caulis was used to measure the maximum diameter of erosive and atrophic lesions and the maximum width perpendicular to the maximum diameter was recorded.", 
            "measure": "size of lesions", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "source": "Mashhad University of Medical Sciences", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mashhad University of Medical Sciences", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}